BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

NCT02936492 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: BAY1003803 0.01% lipophilic cream
DRUG: BAY1003803 0.1% lipophilic cream
DRUG: BAY1003803 0.01% ointment
DRUG: BAY1003803 0.1% ointment
DRUG: Lipophilic cream vehicle
DRUG: Ointment vehicle
DRUG: Clobetasol propionate

Sponsor

Bayer